This country profile provides an overview of Mozambique’s progress in reaching those in need of mass NTD treatment based on 2016 data.

NTD mass treatment coverage index: 18/100
Overall rank: 27th

Treatment coverage

Lymphatic filariasis
74%
Onchocerciasis
0%
Schistosomiasis
93%
STH
57%
Trachoma
45%
16.7 million people received treatment in Mozambique in 2016 7.2 million people in need did not receive treatment in Mozambique in 2016

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Mozambique.

Mozambique recommendations

These recommendations were given to heads of state at the African Union summit in January 2017 as part of the ALMA Scorecard for Accountability and Action.

  • Given the good coverage achieved in soil-transmitted helminths (STH), schistosomiasis, trachoma, and lymphatic filariasis preventive chemotherapy, confirm onchocerciasis transmission and undertake onchocerciasis elimination mapping, starting at the Malawi border and before scaling down mass administration for lymphatic filariasis.
  • Increase budget allocation for neglected tropical diseases at the national level.
  • Provide timely data to the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) to enable monitoring and planning.

Lymphatic filariasis

⬆ Treatment coverage increased from 0% in 2015 to 74% in 2016.

People needing treatment
20.2m
People receiving treatment
14.9m

Onchocerciasis

Treatment coverage remained the same at 0% in 2015 and 2016.

People needing treatment
18,000
People receiving treatment
0 reported

Schistosomiasis

⬆ Treatment coverage increased from 0% in 2015 to 93% in 2016.

School-aged children needing treatment
5.8m
School-aged children receiving treatment
5.41m

Soil-transmitted helminths

⬆ Treatment coverage increased from 33% in 2015 to 57% in 2016.

Pre-sch and school-aged children needing treatment
12m
Pre-school and school-aged children receiving treatment
6.82m

Trachoma

⬆ Treatment coverage increased from 42% in 2015 to 45% in 2016.

People needing treatment
6.47m
People receiving treatment
2.94m